These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31374028)
1. Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer. Liu H; Yang L Medicine (Baltimore); 2019 Aug; 98(31):e16620. PubMed ID: 31374028 [TBL] [Abstract][Full Text] [Related]
2. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. Hipkins J; Whitworth M; Tarrier N; Jayson G Br J Health Psychol; 2004 Nov; 9(Pt 4):569-81. PubMed ID: 15509362 [TBL] [Abstract][Full Text] [Related]
3. Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy. Wen Q; Shao Z; Zhang P; Zhu T; Li D; Wang S Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():85-91. PubMed ID: 28738296 [TBL] [Abstract][Full Text] [Related]
4. When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer. Beesley VL; Webber K; Nagle CM; DeFazio A; Obermair A; Williams M; Friedlander M; Webb PM; Gynecol Oncol; 2020 Oct; 159(1):179-186. PubMed ID: 32773150 [TBL] [Abstract][Full Text] [Related]
5. Self-reported distress in patients with ovarian cancer: is it related to disease status? Ploos van Amstel FK; van Ham MA; Peters EJ; Prins JB; Ottevanger PB Int J Gynecol Cancer; 2015 Feb; 25(2):229-35. PubMed ID: 25594140 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Price MA; Zachariae R; Butow PN; deFazio A; Chauhan D; Espie CA; Friedlander M; Webb PM; ; Eur J Cancer; 2009 Dec; 45(18):3262-70. PubMed ID: 19540748 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers. Price MA; Butow PN; Costa DS; King MT; Aldridge LJ; Fardell JE; DeFazio A; Webb PM; ; Med J Aust; 2010 Sep; 193(S5):S52-7. PubMed ID: 21542447 [TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
9. Psychiatric comorbidities among ovarian cancer survivors in South Korea: A nationwide population-based, longitudinal study. Heo J; Chun M; Oh YT; Noh OK; Kim L Psychooncology; 2018 Mar; 27(3):1021-1026. PubMed ID: 29280223 [TBL] [Abstract][Full Text] [Related]
10. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Bodurka-Bevers D; Basen-Engquist K; Carmack CL; Fitzgerald MA; Wolf JK; de Moor C; Gershenson DM Gynecol Oncol; 2000 Sep; 78(3 Pt 1):302-8. PubMed ID: 10985884 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of quality of life, anxiety and depression in testicular cancer patients during chemotherapy and after anticancer treatment]. Osmańska M; Borkowska A; Makarewicz R Psychiatr Pol; 2010; 44(4):543-56. PubMed ID: 20919505 [TBL] [Abstract][Full Text] [Related]
12. OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer. Frangou E; Bertelli G; Love S; Mackean MJ; Glasspool RM; Fotopoulou C; Cook A; Nicum S; Lord R; Ferguson M; Roux RL; Martinez M; Butcher C; Hulbert-Williams N; Howells L; Blagden SP Gynecol Oncol; 2021 Aug; 162(2):431-439. PubMed ID: 34059348 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of psychological status and relevant factors of patients with esophageal and gastric cardia precancerous lesions in Linzhou of Henan]. Ma SR; Ma Q; Hao CQ; Guan CT; Li BY; Wang JW; Li XQ; Liu ZK; Wei WW Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):670-674. PubMed ID: 28763913 [No Abstract] [Full Text] [Related]
14. Effect of virtual reality-based mindfulness training model on anxiety, depression, and cancer-related fatigue in ovarian cancer patients during chemotherapy. Mao W; Chen W; Wang Y Technol Health Care; 2024; 32(2):1135-1148. PubMed ID: 37781832 [TBL] [Abstract][Full Text] [Related]
15. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. Sjoquist KM; Friedlander ML; O'Connell RL; Voysey M; King MT; Stockler MR; Oza AM; Gillies K; Martyn JK; Butow PN Oncologist; 2013; 18(11):1221-8. PubMed ID: 24107972 [TBL] [Abstract][Full Text] [Related]
16. Anxiety and depression in patients with advanced ovarian cancer: a prospective study. Mielcarek P; Nowicka-Sauer K; Kozaka J J Psychosom Obstet Gynaecol; 2016; 37(2):57-67. PubMed ID: 26939616 [TBL] [Abstract][Full Text] [Related]
17. Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. Nho JH; Reul Kim S; Nam JH Eur J Oncol Nurs; 2017 Oct; 30():8-14. PubMed ID: 29031318 [TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955 [TBL] [Abstract][Full Text] [Related]
19. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. Watts S; Prescott P; Mason J; McLeod N; Lewith G BMJ Open; 2015 Nov; 5(11):e007618. PubMed ID: 26621509 [TBL] [Abstract][Full Text] [Related]
20. [Symptoms of depression in cancer patients undergoing chemotherapy]. Middelboe T; Ovesen LF; Mortensen EL; Bech P Ugeskr Laeger; 1995 Mar; 157(13):1849-52. PubMed ID: 7725562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]